Company
Greenwich PartnersLocation
UK-LondonRemuneration
Excellent base and bonusPosition Type
PermanentEmployment type
Full timeUpdated
15-Nov-2013eFC Ref no
1285407
Top US bank wants an ACA with a degree
in biology, pharmacology, lifesciences, medicine or related field to
join their Healthcare and Lifesciences Equity
Our client is a leading sell side firm
who are now looking to recruit an equity research associate to their
team. The position will focus on companies in the broad healthcare and
lifesciences space.
Main Responsibilities / Deliverables:
- ACA/ chartered accountant with a major accounting firm
- a degree in biology, lifesciences, pharmacology, medicine, chemistry, natural sciences or similar field OR very relevant client exposure in the sector
- real interest in financial markets
Main Responsibilities / Deliverables:
- Developing a clear understanding of how the business models and industry dynamics of companies under coverage work.
- Writing detailed and thought provoking research on the companies under coverage with both an eye to the short term view as well as the longer-term drivers of value
- Dealing with company results. This would typically entail giving a "first glance" opinion, writing an initial post-results comment and talking through the results with the sales desk. Later on it would entail writing a note post the results meeting/conference call and going through any forecast changes in detail
- Liaising with company management to keep abreast of any developments
- Liaising with the sales desk and market maker to inform them of any developments that may affect the company's share price or give rise to a change in their opinion
- Assisting the team with any ad-hoc work. This is most likely to involve client requests
- Able to demonstrate drive and commitment to pursuing career in Equity Research
- ACA/ chartered accountant with a major accounting firm
- a degree in biology, lifesciences, pharmacology, medicine, chemistry, natural sciences or similar field OR very relevant client exposure in the sector
- real interest in financial markets
0 comments:
Post a Comment